As of November 2026 Scribe Therapeutics has a market cap of A$0.45 Billion. This makes Scribe Therapeutics the world's 8353th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 8th, 2026 the market cap of Scribe Therapeutics was reported to be: